Bliss Aesthetics is a technology company.
Bliss Aesthetics has raised $18.0M across 1 funding round.
Bliss Aesthetics has raised $18.0M in total across 1 funding round.
Bliss Aesthetics has raised $18.0M in total across 1 funding round.
Bliss Aesthetics's investors include AngelPad, B Capital Group, Kamran Ansari, Pareto Holdings, Shine Capital, Stellation Capital, Valar Ventures, Marc Lore, Clark Landry, Ellie Wheeler.
Bliss Aesthetics is a health tech startup founded in 2022 that builds an AI-powered digital platform connecting patients seeking cosmetic surgery with board-certified plastic surgeons.[1][2][3][4] It serves individuals pursuing aesthetic enhancements by solving key pain points in a fragmented industry: discovering trustworthy providers, visualizing realistic outcomes via tools like Bliss Imagine (using generative AI, Stable Diffusion, and computer vision), accessing virtual consultations, transparent pricing, flexible financing (as low as 0%), and end-to-end support including aftercare.[1][2][3][4] The platform has demonstrated strong growth momentum, raising $17.5 million in seed funding in April 2025 (led by Shine Capital, with Synchrony Ventures, Sheva Ventures, Point72 Ventures, and Cerca Partners), expanding its provider network by 500%, boosting clinic patient conversion rates from 40% to 80%, and entering five new U.S. states amid a global aesthetic medicine market projected to hit $200 billion in a decade.[1][3]
Bliss Aesthetics was founded in 2022 in Encinitas, California, by Co-Founder and CEO Gal Yosef and Co-Founder and Chief Medical Officer Dr. Michael Salzhauer (known as Dr. Miami, a prominent plastic surgeon).[1][2][3] The idea emerged from recognizing the cosmetic surgery industry's fragmentation—patients struggle to find qualified surgeons, visualize results, and navigate financing, while providers face administrative burdens and low conversion rates.[1][3][4] Early traction came quickly post-launch, with 500% provider network growth, improved patient engagement from 40% to 80%, and the April 2025 $17.5M seed round fueling U.S. expansion; earlier funding totaled around $300K.[1][2][3] This pivotal funding validates their patient-first approach, blending Yosef's tech expertise with Salzhauer's medical credibility to humanize a high-stakes personal decision.[1][3]
Bliss rides the convergence of AI in healthcare and booming aesthetic medicine demand—25% of Americans have had procedures, with 55% growth expected among men, in a market heading to $200B.[1][3] Timing is ideal post-2025 funding, as GenAI democratizes personalized medicine amid rising telehealth and consumer wellness spending.[1][3] Favorable forces include fragmented competition (direct-to-surgeon bookings limit options) and financing gaps, which Bliss addresses via tech-enabled transparency.[3][4] It influences the ecosystem by empowering patients with data-driven decisions, scaling providers efficiently, and setting a model for AI concierges in elective care, potentially accelerating industry consolidation and outcome-focused innovation.[1][3]
Bliss is poised for national dominance with its $17.5M war chest enabling five-state expansion and further AI enhancements, targeting the $200B market through deeper provider integration and international scaling.[1][3] Trends like AI personalization, male aesthetics surge, and embedded financing will propel growth, while partnerships (e.g., Synchrony) could unlock volume-based innovations.[1][3] Its influence may evolve from niche connector to category leader, redefining cosmetic care as accessible, tech-native transformations—proving AI can humanize high-touch decisions in a $200B frontier.[1][3]
Bliss Aesthetics has raised $18.0M across 1 funding round. Most recently, it raised $18.0M Seed in April 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2025 | $18.0M Seed | AngelPad, B Capital Group, Kamran Ansari, Pareto Holdings, Shine Capital, Stellation Capital, Valar Ventures, Marc Lore, Clark Landry, Ellie Wheeler |